Now Accepting Public Comments through June 8, 2026 on the Draft 2027 CMS QRDA III Implementation Guide, Schematron, and Sample File for Eligible Clinicians
Constrained to 'Substance with angiotensin II receptor antagonist mechanism of action (substance)' SNOMEDCT code
Data elements that meet criteria using this datatype should document the allergy or intolerance and its corresponding value set.
Timing: